Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -173,407 | -148,656 | -350,125 | -364,078 | -300,106 |
| Depreciation Amortization | 135,652 | 67,931 | 277,706 | 229,018 | 153,643 |
| Income taxes - deferred | -1,753 | 1,680 | -132,231 | -62,989 | -79,486 |
| Accounts receivable | 1,742 | 1,064 | -84,444 | -101,612 | -97,267 |
| Accounts payable and accrued liabilities | -3,592 | 6,528 | -16,521 | -18,414 | 29,823 |
| Other Working Capital | -52,178 | -43,126 | 184,254 | 44,851 | 48,580 |
| Other Operating Activity | 94,510 | 53,768 | 405,701 | 414,304 | 317,544 |
| Operating Cash Flow | $974 | $-60,811 | $284,340 | $141,080 | $72,731 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -762 | -665 | -4,336 | -4,028 | -2,627 |
| Net Acquisitions | N/A | N/A | -97,849 | -99,746 | -98,778 |
| Purchase Sale Intangibles | -12,000 | -12,000 | N/A | N/A | N/A |
| Other Investing Activity | -12,000 | -12,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-12,762 | $-12,665 | $-102,185 | $-103,774 | $-101,405 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,693,512 | 847,768 | 847,768 |
| Debt Repayment | -27,722 | -2,125 | -1,622,749 | -774,875 | -774,875 |
| Common Stock Issued | 8,406 | 945 | 11,038 | 7,407 | 5,164 |
| Common Stock Repurchased | N/A | N/A | -992 | -992 | -992 |
| Other Financing Activity | -9,185 | -3,503 | -26,533 | -5,640 | -5,202 |
| Financing Cash Flow | $-28,501 | $-4,683 | $54,276 | $73,668 | $71,863 |
| Exchange Rate Effect | -1,003 | 982 | 5,316 | 4,366 | 2,196 |
| Beginning Cash Position | 757,897 | 757,897 | 516,150 | 516,150 | 516,150 |
| End Cash Position | 716,605 | 680,720 | 757,897 | 631,490 | 561,535 |
| Net Cash Flow | $-41,292 | $-77,177 | $241,747 | $115,340 | $45,385 |
| Free Cash Flow | |||||
| Operating Cash Flow | 974 | -60,811 | 284,340 | 141,080 | 72,731 |
| Capital Expenditure | -762 | -665 | -4,336 | -4,028 | -2,627 |
| Free Cash Flow | 212 | -61,476 | 280,004 | 137,052 | 70,104 |